login
login
Image header Agence Europe
Europe Daily Bulletin No. 13023
Contents Publication in full By article 15 / 29
EU RESPONSE TO COVID-19 / Health

EMA recommends continued authorisation of Moderna and BioNTech-Pfizer’s ‘Covid’ vaccines

The European Medicines Agency (EMA) announced on Friday 16 September, following the meeting of its Committee for Medicinal Products for Human Use (CHMP) (12-15 September), that it recommended converting the conditional marketing authorisations granted to the Covid-19 messenger RNA vaccines Comirnaty, developed by Pfizer andBioNTech, and Spikevax, developed by Moderna, into a standard marketing authorisation. This decision is taken during the second annual renewal procedure of this...

Contents

FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
SECTORAL POLICIES
INSTITUTIONAL
EXTERNAL ACTION
EU RESPONSE TO COVID-19
EUROPEAN PARLIAMENT PLENARY
COUNCIL OF EUROPE
NEWS BRIEFS
ADDENDUM